✨ Your Portfolio is fetched and updated from zerodha.
Nano Chemicals
Market Cap
₹134 Cr.
P/E
9.48
  • Par Drugs & Chem.
  • Polson
  • Resonance Specialtie

FAQs on Par Drugs And Chemicals Ltd. Shareprice

Par Drugs & Chem. has given better returns compared to its competitors.
Par Drugs & Chem. has grown at ~30.46% over the last 6yrs while peers have grown at a median rate of 11.48%

Par Drugs & Chem. is not expensive.
Latest PE of Par Drugs & Chem. is 9.77, while 3 year average PE is 17.77.
Also latest EV/EBITDA of Par Drugs & Chem. is 5.86 while 3yr average is 10.21.

Growth Table

  • Par Drugs And Chemicals Ltd.
  • Polson
  • Resonance Specialtie

Balance Sheet

  • Par Drugs And Chemicals Ltd.
  • Polson
  • Resonance Specialtie

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Par Drugs And Chemicals Ltd.
  • Polson
  • Resonance Specialtie

Cash Flow

  • Par Drugs And Chemicals Ltd.
  • Polson
  • Resonance Specialtie

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Par Drugs And Chemicals Ltd.
  • Polson
  • Resonance Specialtie

Quarterly Results

  • Par Drugs And Chemicals Ltd.
  • Polson
  • Resonance Specialtie

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Par Drugs And Chemicals Ltd. Financials

Balance sheet of Par Drugs & Chem. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Par Drugs & Chem. is increasing.
Latest net debt of Par Drugs & Chem. is -₹27.58 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹73.29 Crs.

The profit is oscillating.
The profit of Par Drugs & Chem. is ₹14.15 Crs for TTM, ₹14.5 Crs for Mar 2024 and ₹11.33 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Par Drugs & Chem. latest dividend payout ratio is 16.69% and 3yr average dividend payout ratio is 16.69%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech